Aptima Combo 2®
Aptima Combo 2® Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro…
Aptima Combo 2® Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal disease using the Panther® System as specified.
Who Else Makes It
Registered in Guangdong. One is registered as a contract manufacturer, able to build to a specification.
| Manufacturer | City | Province | Registered as | Device types |
|---|---|---|---|---|
| Hochuen Medical Technology Co., Ltd. | Shenzhen | Guangdong | Contract manufacturer | 20 |
Record
| Listed by | Hologic, Inc., United States |
|---|---|
| FDA product code | QEP |
| Device type | Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections |
| Device class | Class 2 |
| Regulation | 21 CFR 866.3393 |
| Establishment | Remanufacturer, Specification developer, Complaint-file establishment, Manufacturer, Exporter |
| Record published | 2020-06-16 |
| Record revised | 2024-07-22 (version 4) |
Specifications
| MRI safety | Labeling does not contain MRI Safety Information |
|---|---|
| Prescription | Prescription only |
| Label carries | lot or batch number, expiry date |
| Storage | Storage environment temperature 2 to 8 °C |
| UDI direct marking | Exempt |
Catalogue Numbers
| Catalogue number | Size | Status |
|---|---|---|
| KIT,APTIMACOMBO2,250T,REF,CEIVD-UPDATED | In distribution | |
| KIT, BX 2 (RT) AC2, 100T, AS, IVD | In distribution |
Same Product Code
| Product | Sold by | Catalogue numbers |
|---|---|---|
| Aptima | Hologic, Inc. | 5 |
| Alinity m | Abbott Molecular, Inc. | 4 |
| Xpert CT/NG | Cepheid | 2 |
| cobas® TV/MG | Roche Molecular Systems, Inc. | 2 |
| cobas® TV/MG Positive Control Kit | Roche Molecular Systems, Inc. | 2 |
| binx io | Binx Health, Ltd. | 1 |
| Visby Medical Men’s Sexual Health Test | Visby Medical, Inc. | 1 |
| BD COR CTGCTV2 US | Becton, Dickinson AND Company | 1 |
510(K) Clearances
| Clearance | Decision date |
|---|---|
| K220321 | 2022-06-03 |
| K200866 | 2020-05-17 |
| K200436 | 2020-03-23 |
| K190515 | 2019-05-23 |
| DEN180047 | 2019-01-23 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.